These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2504995)

  • 1. Prostacyclin mediates splanchnic vascular response to norepinephrine in portal hypertension.
    Sitzmann JV; Li SS; Lin PW
    J Surg Res; 1989 Sep; 47(3):208-11. PubMed ID: 2504995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of splanchnic vascular sensitivity to angiotensin II.
    Wu YP; Li SS; Campbell KA; Sitzmann JV
    Surgery; 1991 Aug; 110(2):162-8. PubMed ID: 1907031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of prostacyclin in the splanchnic hyperemia contributing to portal hypertension.
    Sitzmann JV; Bulkley GB; Mitchell MC; Campbell K
    Ann Surg; 1989 Mar; 209(3):322-7. PubMed ID: 2493776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostacyclin production in acute, chronic, and long-term experimental portal hypertension.
    Sitzmann JV; Campbell K; Wu Y; St Clair C
    Surgery; 1994 Mar; 115(3):290-4. PubMed ID: 8128353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamics in portal hypertension.
    Wu Y; Burns RC; Sitzmann JV
    Hepatology; 1993 Dec; 18(6):1416-21. PubMed ID: 8244267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for role of prostacyclin as a systemic hormone in portal hypertension.
    Sitzmann JV; Li SS; Adkinson NF
    Surgery; 1991 Feb; 109(2):149-53. PubMed ID: 1992548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced cyclooxygenase-1 expression within the superior mesenteric artery of portal hypertensive rats: role in the hyperdynamic circulation.
    Hou MC; Cahill PA; Zhang S; Wang YN; Hendrickson RJ; Redmond EM; Sitzmann JV
    Hepatology; 1998 Jan; 27(1):20-7. PubMed ID: 9425912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased mesenteric vascular response to angiotensin II in portal hypertension.
    Sitzmann JV; Li SS; Wu YP; Groszmann R; Bulkley GB
    J Surg Res; 1990 Apr; 48(4):341-4. PubMed ID: 2338820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.
    Xu J; Cao H; Liu H; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and chronic cyclooxygenase blockage in portal-hypertensive rats: influence in nitric oxide biosynthesis.
    Fernández M; García-Pagán JC; Casadevall M; Mourelle MI; Piqué JM; Bosch J; Rodés J
    Gastroenterology; 1996 May; 110(5):1529-35. PubMed ID: 8613060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of portosystemic shunting by prostacyclin in portal hypertension.
    Campbell KA; Wu YP; Sitzmann JV
    Curr Surg; 1990; 47(1):17-9. PubMed ID: 2107062
    [No Abstract]   [Full Text] [Related]  

  • 12. Gender differences in vascular reactivity of mesenteric arterioles in portal hypertensive and non-portal hypertensive rats.
    Zhang B; Ji LH; Zhang CG; Zhao G; Wu ZY
    World J Gastroenterol; 2019 Oct; 25(39):5953-5960. PubMed ID: 31660032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of prostacyclin by indomethacin ameliorates the splanchnic hyposensitivity to glypressin in haemorrhage-transfused common bile duct-ligated rats.
    Lee FY; Chu CJ; Wang SS; Chang FY; Lin HC; Hou MC; Chan CC; Wu SL; Chen CT; Huang HC; Lee SD
    Eur J Clin Invest; 2001 Feb; 31(2):145-53. PubMed ID: 11168453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of prostacyclin inhibition on splanchnic hyposensitivity to glypressin in a hemorrhage-transfused rat model of portal hypertension.
    Wang SS; Chu CJ; Lee FY; Wu SL; Lin HC; Chan CC; Chang FY; Lee SD
    Scand J Gastroenterol; 2000 Apr; 35(4):426-32. PubMed ID: 10831268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y restores non-receptor-mediated vasoconstrictive action in superior mesenteric arteries in portal hypertension.
    Hartl J; Dietrich P; Moleda L; Müller-Schilling M; Wiest R
    Liver Int; 2015 Dec; 35(12):2556-63. PubMed ID: 26010514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II increases portosystemic collateral resistance in portal hypertension.
    Campbell KA; Wu YP; Sitzmann JV
    J Surg Res; 1991 Sep; 51(3):181-5. PubMed ID: 1881131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of PGI2 in the formation and maintenance of hyperdynamic circulatory state of portal hypertensive rats.
    Wu ZY; Chen XS; Qiu JF; Cao H
    World J Gastroenterol; 2005 Feb; 11(5):752-5. PubMed ID: 15655838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
    Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostacyclin decreases splanchnic vascular contractility in cirrhotic rats.
    Liu DJ; Chen W; Huo YM; Liu W; Zhang JF; Hua R; Sun YW
    Hepatobiliary Pancreat Dis Int; 2014 Aug; 13(4):416-22. PubMed ID: 25100127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic and portal prostacyclin and thromboxane response to hemorrhage in portal hypertension.
    Wu Y; Burns C; Campbell KA; Sitzmann JV
    Shock; 1994 Jul; 2(1):68-71. PubMed ID: 7735986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.